Table 5.
Patterns of Medication Use
| Drug/Class | Hospital Discharge |
90 d |
||||||
|---|---|---|---|---|---|---|---|---|
| Usual Care N=13 |
Education Alone N=18 |
ACT N=15 |
P-Value | Usual Care N=13 |
Education Alone N=18 |
ACT N=15 |
P Value | |
| ACEi | 2 (15) | 3 (17) | 2 (13) | 0.97 | 2 (15) | 4 (22) | 4 (27) | 0.77 |
| ARB | 2 (15) | 0 (0) | 1 (7) | 0.23 | 2 (15) | 0 (0) | 0 (0) | 0.07 |
| NSAID | 2 (15) | 0 (0) | 0 (0) | 0.07 | 1 (8) | 0 (0) | 0 (0) | 0.27 |
| Loop diuretic | 5 (39) | 9 (50) | 4 (27) | 0.39 | 5 (39) | 9 (50) | 2 (13) | 0.08 |
| Spironolactone | 0 (0) | 0 (0) | 1 (7) | 0.35 | 1 (8) | 0 (0) | 1 (7) | 0.51 |
| SGLT2i | 0 (0) | 0 (0) | 0 (0) | - | 0 (0) | 0 (0) | 1 (7) | 0.35 |
| SMX/TMP | 1 (8) | 1 (6) | 2 (13) | 0.72 | 1 (8) | 0 (0) | 1 (7) | 0.51 |
| Calcineurin inhibitor | 1 (8) | 3 (17) | 1 (7) | 0.60 | 1 (8) | 3 (17) | 0 (0) | 0.24 |
Note: Data reported as n (%).
Abbreviations: ACT, AKI in Care Transition; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; NSAID, nonsteroidal anti-inflammatory drug; SGLT2i, sodium-glucose cotransporter-2 inhibitor; SMX/TMP, sulfamethoxazole-trimethoprim.